Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1990 2
1991 1
1993 1
1994 1
1995 1
1996 2
1997 2
1998 1
1999 7
2000 2
2001 3
2002 4
2003 1
2004 2
2005 3
2006 6
2007 4
2008 8
2009 5
2010 11
2011 11
2012 9
2013 11
2014 11
2015 11
2016 10
2017 9
2018 10
2019 22
2020 16
2021 18
2022 21
2023 25
2024 24
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for port cv
Search for Porto CV instead (2 results)
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team. Carpp LN, et al. Nat Commun. 2024 Nov 12;15(1):9785. doi: 10.1038/s41467-024-53727-y. Nat Commun. 2024. PMID: 39532861 Free PMC article. Clinical Trial.
Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer.
Shigyo H, Suzuki H, Tanaka T, Moriyama E, Shimotsuura Y, Nagasu S, Iwamoto H, Akagi Y, Murotani K, Kawaguchi T, Miwa K. Shigyo H, et al. Cancers (Basel). 2023 Apr 12;15(8):2264. doi: 10.3390/cancers15082264. Cancers (Basel). 2023. PMID: 37190192 Free PMC article.
However, the safety of BEV administration immediately after surgical placement of the central venous (CV) port, a minor surgery, is still unclear. This study aimed to investigate whether BEV is safe when administered early after CV port placement. ...I …
However, the safety of BEV administration immediately after surgical placement of the central venous (CV) port, a minor surger …
Central venous access port placement by translumbar approach using angio-CT unit in patients with superior vena cava syndrome.
Kariya S, Nakatani M, Maruyama T, Ono Y, Ueno Y, Komemushi A, Tanigawa N. Kariya S, et al. Jpn J Radiol. 2018 Jul;36(7):450-455. doi: 10.1007/s11604-018-0742-3. Epub 2018 May 9. Jpn J Radiol. 2018. PMID: 29744732
PURPOSE: To evaluate the clinical results of central venous access port (CV port) placement by translumbar inferior vena cava cannulation using angio-CT unit for cancer patients with superior vena cava syndrome. MATERIALS AND METHODS: A CV port …
PURPOSE: To evaluate the clinical results of central venous access port (CV port) placement by translumbar inferior ven …
Immersive Virtual Reality for Reducing Intraoperative Pain: A Pilot Randomized Controlled Trial.
Kamada T, Ohdaira H, Nishie R, Yamagishi D, Aida T, Takahashi J, Ito E, Ryu S, Narihiro S, Takizawa R, Hata T, Yoshida M, Eto K, Sumi M, Suzuki Y. Kamada T, et al. In Vivo. 2025 May-Jun;39(3):1638-1646. doi: 10.21873/invivo.13964. In Vivo. 2025. PMID: 40294990 Free PMC article. Clinical Trial.
BACKGROUND/AIM: In this study, we aimed to evaluate the effect of virtual reality (VR) therapy on pain, anxiety, and other outcomes in patients with cancer undergoing central venous (CV) port placement. PATIENTS AND METHODS: We conducted a single-center randomized c …
BACKGROUND/AIM: In this study, we aimed to evaluate the effect of virtual reality (VR) therapy on pain, anxiety, and other outcomes in patie …
Factors for bloodstream infection in totally implantable venous-access ports.
Ishikawa K, Kataoka K, Ueda T, Ito K, Ichiki K, Nishimura Y, Mizukuchi C, Fukumoto Y, Yanagawa T, Einari M, Ohashi E, Kimura K, Uchino M, Horio Y, Nakajima K, Ikeda M. Ishikawa K, et al. J Infect Chemother. 2025 Sep;31(9):102783. doi: 10.1016/j.jiac.2025.102783. Epub 2025 Aug 6. J Infect Chemother. 2025. PMID: 40780408 Free article.
INTRODUCTION: Central line-associated bloodstream infection (CLABSI) associated with implanted central venous (CV)-access ports (CV ports) remains one of the most serious complications that can worsen patient outcomes. ...CONCLUSION: Close monitoring is essential wh …
INTRODUCTION: Central line-associated bloodstream infection (CLABSI) associated with implanted central venous (CV)-access ports (C …
Contrast examination of central venous access port implanted through internal jugular vein for evaluation of suspected complications.
Iguchi T, Hiraki T, Matsui Y, Tomita K, Uka M, Umakoshi N, Kajita S, Komaki T, Gobara H, Kanazawa S. Iguchi T, et al. Jpn J Radiol. 2021 Nov;39(11):1103-1110. doi: 10.1007/s11604-021-01142-4. Epub 2021 May 22. Jpn J Radiol. 2021. PMID: 34021855
Contrast examination was performed due to three suspicion catheter fractures or 54 CV-port dysfunctions (combinations of an absence of blood reflux on aspiration and 9 sufficient, 21 insufficient, or 24 impossible drip infusions). ...Five cases could not undergo con …
Contrast examination was performed due to three suspicion catheter fractures or 54 CV-port dysfunctions (combinations of an ab …
Central venous access Port-Related blood stream infection caused by Cyberlindnera fabianii: A case report and literature review.
Kawasaki K, Sawai T, Inadomi Y, Morimitsu S, Ikeda T, Yoshioka S, Matsuo N, Kadota J, Yanagihara K, Mukae H. Kawasaki K, et al. J Infect Chemother. 2025 Apr;31(4):102662. doi: 10.1016/j.jiac.2025.102662. Epub 2025 Mar 7. J Infect Chemother. 2025. PMID: 40057275 Free article. Review.
Here, we describe the first reported case of central venous (CV) access port-related blood-stream infection caused by C. fabianii. An 80-year-old Asian man presented to our department with a mass in the pancreas. A diagnosis of pancreatic cancer (cT4N0M0, cStage III …
Here, we describe the first reported case of central venous (CV) access port-related blood-stream infection caused by C. fabia …
Application of wireless energy transmission technology into central venous ports with light-emitting diodes.
Yasutomi M, Yunaiyama D, Takara Y, Saguchi T, Nakai M, Saito K. Yasutomi M, et al. Lasers Med Sci. 2023 Sep 13;38(1):212. doi: 10.1007/s10103-023-03867-2. Lasers Med Sci. 2023. PMID: 37702826
Implantable central venous (CV) ports are widely used for chemotherapy and parenteral nutrition. Generally, CV ports are used safely; however, some patients suffer from drug leakage around the port septum due to mispuncture. Therefore, we developed a CV …
Implantable central venous (CV) ports are widely used for chemotherapy and parenteral nutrition. Generally, CV ports are used …
Practical use of the central venous access port for contrast-enhanced CT: comparison with peripheral intravenous access regarding enhancement and safety.
Washio H, Kashimoto K, Sakashita N, Ohira S, Tanaka J, Maeda N, Shimada M, Kawamata M, Yoneda A, Nakanishi K. Washio H, et al. Clin Radiol. 2024 Mar;79(3):213-220. doi: 10.1016/j.crad.2023.12.010. Epub 2024 Jan 3. Clin Radiol. 2024. PMID: 38218706
AIM: To evaluate the efficacy of using the central venous (CV) port compared with peripheral intravenous access for contrast-material injection for contrast enhancement during the portal venous phase. ...The median peak injection pressure was 73.5, 67, and 47 psi in …
AIM: To evaluate the efficacy of using the central venous (CV) port compared with peripheral intravenous access for contrast-m …
271 results